South-East Asia (WHO region) vs Uzbekistan: Confirmed cases of MDR-TB
South-East Asia (WHO region)
19,202
in 2012
Uzbekistan
1,728
in 2012
South-East Asia (WHO region) rank
5th
Uzbekistan rank
6th
Confirmed cases of MDR-TB over time
- South-East Asia (WHO region)
- Uzbekistan
How they compare
South-East Asia (WHO region) currently reports 19,202 against 1,728 in Uzbekistan, a difference of 17,474.
That makes South-East Asia (WHO region)'s figure about 11.1 times Uzbekistan's.
The two have swapped places 1 time across 8 shared years of data; in 2005 it was Uzbekistan ahead.
South-East Asia (WHO region) ranks 5th and Uzbekistan ranks 6th of 11 groups.
South-East Asia (WHO region) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South-East Asia (WHO region) | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1,208 | 329.8 | 878.6 | South-East Asia (WHO region) |
| 2010s | 9,920 | 1,379 | 8,541 | South-East Asia (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of mdr-tb, South-East Asia (WHO region) or Uzbekistan?
- South-East Asia (WHO region), at 19,202 against 1,728 in Uzbekistan as of 2012.
- What is the difference in confirmed cases of mdr-tb between South-East Asia (WHO region) and Uzbekistan?
- 17,474, with South-East Asia (WHO region) ahead.
- How many years of comparable data are there for South-East Asia (WHO region) and Uzbekistan?
- 8 years are reported by both, from 2005 to 2012.
- How do South-East Asia (WHO region) and Uzbekistan rank globally for confirmed cases of mdr-tb?
- South-East Asia (WHO region) ranks 5th and Uzbekistan ranks 6th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of MDR-TB. Statizoid refreshes it automatically from the source and publishes the full history for both places.